{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:37:57Z","timestamp":1777480677812,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00198-014-2992-y","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T11:16:26Z","timestamp":1418728586000},"page":"1063-1071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Local renin-angiotensin system is associated with bone mineral density of glucocorticoid-induced osteoporosis patients"],"prefix":"10.1007","volume":"26","author":[{"given":"B.","family":"Shuai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. P.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X. J.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Rong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"2992_CR1","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/qjmed\/hci029","volume":"98","author":"TP Staa van","year":"2005","unstructured":"van Staa TP, Geusens P, Pols HA, de Laet C, Leufkens HG, Cooper C (2005) A simple score for estimating the long-term risk of fracture in patients using oral glucocorticoids. QJM 98:191\u2013198","journal-title":"QJM"},{"key":"2992_CR2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00223-006-0019-1","volume":"79","author":"TP Staa van","year":"2006","unstructured":"van Staa TP (2006) The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 79:129\u2013137","journal-title":"Calcif Tissue Int"},{"key":"2992_CR3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00223-012-9630-5","volume":"91","author":"R Rizzoli","year":"2012","unstructured":"Rizzoli R, Adachi JD, Cooper C, Dere W, Devogelaer JP, Diez-Perez A, Kanis JA, Laslop A, Mitlak B, Papapoulos S, Ralston S, Reiter S, Werhya G, Reginster JY (2012) Management of glucocorticoid-induced osteoporosis. Calcif Tissue Int 91:225\u2013243","journal-title":"Calcif Tissue Int"},{"key":"2992_CR4","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","volume":"23","author":"Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstr\u00f6m F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF-ECTS GIO Guidelines Working Group","year":"2012","unstructured":"Lekamwasam S, Adachi JD, Agnusdei D, Bilezikian J, Boonen S, Borgstr\u00f6m F, Cooper C, Diez Perez A, Eastell R, Hofbauer LC, Kanis JA, Langdahl BL, Lesnyak O, Lorenc R, McCloskey E, Messina OD, Napoli N, Obermayer-Pietsch B, Ralston SH, Sambrook PN, Silverman S, Sosa M, Stepan J, Suppan G, Wahl DA, Compston JE; Joint IOF-ECTS GIO Guidelines Working Group (2012) A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis. Osteoporos Int 23:2257\u20132276","journal-title":"Osteoporos Int"},{"key":"2992_CR5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1677\/joe.0.1560543","volume":"156","author":"H Hagiwara","year":"1998","unstructured":"Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S (1998) Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 156:543\u2013550","journal-title":"J Endocrinol"},{"key":"2992_CR6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1677\/joe.0.1520005","volume":"152","author":"R Hatton","year":"1997","unstructured":"Hatton R, Stimpel M, Chambers TJ (1997) Angiotensin II is generated from angiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152:5\u201310","journal-title":"J Endocrinol"},{"key":"2992_CR7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00774-010-0209-9","volume":"29","author":"YY Liu","year":"2011","unstructured":"Liu YY, Yao WM, Wu T, Xu BL, Chen F, Cui L (2011) Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab 29:149\u2013158","journal-title":"J Bone Miner Metab"},{"key":"2992_CR8","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1096\/fj.07-098954","volume":"22","author":"H Shimizu","year":"2008","unstructured":"Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R (2008) Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465\u20132475","journal-title":"FASEB J"},{"key":"2992_CR9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1359\/jbmr.081006","volume":"24","author":"Y Asaba","year":"2009","unstructured":"Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K (2009) Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241\u2013250","journal-title":"J Bone Miner Res"},{"key":"2992_CR10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S1734-1140(12)70882-4","volume":"64","author":"BO Donmez","year":"2012","unstructured":"Donmez BO, Ozdemir S, Sarikanat M, Yaras N, Koc P, Demir N, Karayalcin B, Oguz N (2012) Effect of angiotensin II type 1 receptor blocker on osteoporotic rat femurs. Pharmacol Rep 64:878\u2013888","journal-title":"Pharmacol Rep"},{"key":"2992_CR11","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1002\/jbmr.501","volume":"26","author":"K Kaneko","year":"2011","unstructured":"Kaneko K, Ito M, Fumoto T, Fukuhara R, Ishida J, Fukamizu A, Ikeda K (2011) Physiological function of the angiotensin AT1a receptor in bone remodeling. J Bone Miner Res 26:2959\u20132966","journal-title":"J Bone Miner Res"},{"key":"2992_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0895-7061(02)03263-6","volume":"16","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2003","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Justo I, Silva J, Sanz A, Mart\u00edn-Escudero JC, Igea R, Escudero P, Pueyo C, Diaz C, Hern\u00e1ndez G, Due\u00f1as A (2003) Relationship between bone mineral density and angiotensin converting enzyme polymorphism in hypertensive postmenopausal women. Am J Hypertens 16:233\u2013235","journal-title":"Am J Hypertens"},{"key":"2992_CR13","first-page":"2200","volume":"86","author":"D Woods","year":"2001","unstructured":"Woods D, Onambele G, Woledge R, Skelton D, Bruce S, Humphries SE, Montgomery H (2001) Angiotensin-I converting enzyme genotype-dependent benefit from hormone replacement therapy in isometric muscle strength and bone mineral density. J Clin Endocrinol Metab 86:2200\u20132204","journal-title":"J Clin Endocrinol Metab"},{"key":"2992_CR14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejphar.2008.02.090","volume":"585","author":"D Iusuf","year":"2008","unstructured":"Iusuf D, Henning RH, van Gilst WH, Roks AJ (2008) Angiotensin-(1\u20137): pharmacological properties and pharmacotherapeutic perspectives. Eur J Pharmacol 585:303\u2013312","journal-title":"Eur J Pharmacol"},{"key":"2992_CR15","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.bone.2005.09.011","volume":"38","author":"H Lynn","year":"2006","unstructured":"Lynn H, Kwok T, Wong SY, Woo J, Leung PC (2006) Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584\u2013388","journal-title":"Bone"},{"key":"2992_CR16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","volume":"24","author":"L Rejnmark","year":"2006","unstructured":"Rejnmark L, Vestergaard P, Mosekilde L (2006) Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study. J Hypertens 24:581\u2013589","journal-title":"J Hypertens"},{"key":"2992_CR17","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00004872-199405000-00003","volume":"12","author":"A Sato","year":"1994","unstructured":"Sato A, Suzuki H, Nakazato Y, Shibata H, Inagami T, Saruta T (1994) Increased expression of vascular angiotensin II type 1A receptor gene in glucocorticoid-induced hypertension. J Hypertens 12:511\u2013516","journal-title":"J Hypertens"},{"key":"2992_CR18","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1152\/ajpregu.2001.280.1.R25","volume":"280","author":"ML Barreto-Chaves","year":"2001","unstructured":"Barreto-Chaves ML, Aneas I, Krieger JE (2001) Glucocorticoid regulation of angiotensin-converting enzyme in primary culture of adult cardiac fibroblasts. Am J Physiol Requl Integr Comp Physiol 280:R25\u2013R32","journal-title":"Am J Physiol Requl Integr Comp Physiol"},{"key":"2992_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000227803","volume":"24","author":"SG Roy","year":"2009","unstructured":"Roy SG, De P, Mukherjee D, Chander V, Konar A, Bandyopadhyay D, Bandyopadhyay A (2009) Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway. Cell Physiol Biochem 24:1\u201310","journal-title":"Cell Physiol Biochem"},{"key":"2992_CR20","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1476-5381.2010.00651.x","volume":"159","author":"P Garcia","year":"2010","unstructured":"Garcia P, Schwenzer S, Slotta JE, Scheuer C, Tami AE, Holstein JH, Histing T, Burkhardt M, Pohlemann T, Menger MD (2010) Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation\u2014role of a local renin-angiotensin system. Br J Pharmacol 159:1672\u20131680","journal-title":"Br J Pharmacol"},{"key":"2992_CR21","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1074\/jbc.M807610200","volume":"284","author":"Y Izu","year":"2009","unstructured":"Izu Y, Mizoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M (2009) Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284:4857\u20134864","journal-title":"J Biol Chem"},{"key":"2992_CR22","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1357-2725(02)00278-9","volume":"35","author":"IC Haznedaroglu","year":"2003","unstructured":"Haznedaroglu IC, Ozturk MA (2003) Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system. Int J Biochem Cell Biol 35:867\u2013880","journal-title":"Int J Biochem Cell Biol"},{"key":"2992_CR23","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1476-5381.1996.tb16032.x","volume":"119","author":"H Mitani","year":"1996","unstructured":"Mitani H, Bandoh T, Ishikawa J, Kimura M, Totsuka T, Hayashi S (1996) Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits. Br J Pharmacol 119:1269\u20131275","journal-title":"Br J Pharmacol"},{"key":"2992_CR24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S8756-3282(98)00165-3","volume":"24","author":"AP Bergula","year":"1999","unstructured":"Bergula AP, Huang W, Frangos JA (1999) Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone 24:171\u2013177","journal-title":"Bone"},{"key":"2992_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10439-005-8967-6","volume":"33","author":"ID McCarthy","year":"2005","unstructured":"McCarthy ID (2005) Fluid shifts due to microgravity and their effects on bone: a review of current knowledge. Ann Biomed Eng 33:95\u2013103","journal-title":"Ann Biomed Eng"},{"key":"2992_CR26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","volume":"26","author":"DH Solomon","year":"2011","unstructured":"Solomon DH, Mogun H, Garneau K, Fischer MA (2011) Risk of fractures in older adults using antihypertensive medications. J Bone Miner Res 26:1561\u20131567","journal-title":"J Bone Miner Res"},{"key":"2992_CR27","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/s12020-014-0196-z","volume":"47","author":"Z Yonqtao","year":"2014","unstructured":"Yonqtao Z, Kunzheng W, Jingjing Z, Hu S, Jianqiang K, Quiyu L, Chunsheng W (2014) Glucocorticoids activate the local renin-angiotensin system in bone: possible mechanism for glucocorticoid-induced osteoporosis. Endocrine 47:598\u2013608","journal-title":"Endocrine"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2992-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-014-2992-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-014-2992-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T13:41:36Z","timestamp":1566135696000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-014-2992-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2992"],"URL":"https:\/\/doi.org\/10.1007\/s00198-014-2992-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]}}}